SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0000950115-00-000427
Filing Date
2000-03-29
Accepted
2000-03-29 00:00:00
Documents
3

Document Format Files

Seq Description Document Type Size
1 FORM S-3 S-3 58729
2 CONSENT OF INDEPENDENT AUDITORS EX-23.1.1 866
3 CONSENT OF INDEPENDENT AUDITORS EX-23.1.2 623
  Complete submission text file 0000950115-00-000427.txt   61816
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO M5J A1
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANA A1 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-33556 | Film No.: 583930
SIC: 2834 Pharmaceutical Preparations